
Phathom Pharmaceuticals, Inc. — Investor Relations & Filings
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing novel treatments for acid-related gastrointestinal (GI) diseases. The company's primary efforts are centered on advancing its lead product candidate, vonoprazan, a potassium-competitive acid blocker (P-CAB). This therapeutic is developed for a range of indications, including the treatment of erosive esophagitis, Helicobacter pylori (H. pylori) infection, and non-erosive reflux disease. Phathom aims to transform the treatment landscape for these conditions by addressing unmet medical needs and improving patient outcomes with innovative therapeutic options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 10-Q - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | |
| 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | |
| ARS - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | |
| DEF 14A - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | |
| S-8 - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-03-27 | English |
Browse filings by year
8 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46753467 | 8-K | 2026-05-21 | English | ||
| 39071239 | 10-Q - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | ||
| 39071212 | 8-K - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-30 | English | ||
| 33707039 | ARS - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | ||
| 33706792 | DEF 14A - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-04-07 | English | ||
| 33065545 | S-8 - Phathom Pharmaceuticals, Inc. (0001783183) (Filer) | 2026-03-27 | English | ||
| 32898205 | 4 - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-03-03 | English | ||
| 32898207 | 10-K - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-02-26 | English | ||
| 32898206 | 8-K - PHATHOM PHARMACEUTICALS, INC. (0001783183) (Filer) | 2026-02-26 | English | ||
| 31697143 | 4 Filing | 2026-02-12 | English | ||
| 31697060 | 4 Filing | 2026-02-12 | English | ||
| 31697051 | SCHEDULE 13G/A Filing | 2026-01-27 | English | ||
| 31696987 | 4 Filing | 2026-01-27 | English | ||
| 31696930 | 4 Filing | 2026-01-23 | English | ||
| 13192726 | 4 | 2026-01-15 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ambrilia Biopharma Inc.
Biopharmaceutical company focused on novel treatments for o…
|
AMB | CA | Manufacturing |
|
AMGEN INC
A biotechnology company developing human therapeutics for s…
|
AMGN | US | Manufacturing |
|
Amicogen, Inc.
Industrial biotechnology company specializing in specialty …
|
092040 | KR | Manufacturing |
|
AMICUS THERAPEUTICS, INC.
Biotechnology company developing therapies for rare genetic…
|
FOLD | US | Manufacturing |
|
AMINOLOGICS CO.,LTD.
Specialty manufacturer of high-purity chiral amino acids an…
|
074430 | KR | Manufacturing |
|
Amneal Pharmaceuticals, Inc.
Develops, manufactures, and distributes generic and special…
|
AMRX | US | Manufacturing |
|
Amoy Diagnostics Co.,Ltd.
Develops molecular diagnostic kits and companion diagnostic…
|
300685 | CN | Manufacturing |
|
Amphastar Pharmaceuticals, Inc.
Develops, manufactures, and markets technically challenging…
|
AMPH | US | Manufacturing |
|
Amrutanjan Health Care Limited
Develops and distributes over-the-counter healthcare and pe…
|
AMRUTANJAN | IN | Manufacturing |
|
Amwill Health Care Limited
Develops, manufactures, and distributes a wide range of med…
|
544353 | IN | Manufacturing |
Phathom Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32407/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32407 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32407 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32407 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32407}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Phathom Pharmaceuticals, Inc. (id: 32407)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.